survodutide

News mentioning survodutide · Wikidata · RSS

Top stories

Latest

1. Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetesGlobeNewswire — all · 2026-10-01 07:30 UTC · 3 more reports